Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice

Hiromi OkamotoDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan; Correspondence[email protected]

Masataka OitateDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan;

Katsunobu HagiharaBiomarker & Translational Research Department, Daiichi Sankyo Co., Ltd, Tokyo, Japan;

Hideyuki ShiozawaDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan;

Yoshitake FurutaDrug Metabolism & Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan;

Yusuke OgitaniOncology Research Laboratories II, Daiichi Sankyo Co., Ltd, Tokyo, Japan;

Hiroshi KugaModality Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan

Your download is now in progress and you may close this window